Table 1
Test of Deficit results and BF values for accuracy (HSAM versus 20 matched controls).
| TASK | HSAM | CONTROLS | t | ESTIMATED % OF CONTROL POPULATION ABOVE DT’S SCORE | ESTIMATED EFFECT SIZE (ZCASE-CONTROLS) | p | BF | ||
|---|---|---|---|---|---|---|---|---|---|
| ACCURACY (%) | MEAN ACCURACY (%) (SD) | (%) | (95% CI) | POINT | (95% CI) | ||||
| Simon Task | |||||||||
| Compatible | 100 | 97.97 (2.42) | 0.82 | 21.16 | 8.94–37.53 | 0.84 | 0.32–1.34 | 0.19 | 3.11 |
| Incompatible | 97 | 92.10 (5.20) | 0.92 | 18.47 | 7.14–34.33 | 0.94 | 0.40–1.47 | 0.19 | 2.97 |
| Part Set Cueing | |||||||||
| Phase 1 | 58.33 | 50.41 (15.35) | 0.50 | 31.02 | 16.38–48.33 | 0.52 | 0.04–0.98 | 0.25 | 4.50 |
| Phase 2 | 62.50 | 50.00 (17.98) | 0.68 | 25.28 | 11.94–42.21 | 0.70 | 0.20–1.18 | 0.25 | 4.04 |
| Phase 3 | 75.00 | 48.75 (18.5) | 1.39 | 9.11 | 2.08–21.72 | 1.42 | 0.78–2.04 | 0.09 | 4.23 |
| Go/No-Go* | |||||||||
| Overall | 99.50 | 95.50 (3.82) | 1.02 | 16.00 | 5.61–31.27 | 1.05 | 0.49–1.59 | 0.16 | 2.56 |
| HSCT | |||||||||
| Phase 1 | 100 | 99.65 (1.60) | 0.21 | 41.66 | 25.41–59.04 | 0.22 | –0.23–0.66 | 0.42 | 4.46 |
| Phase 2 | 85.71 | 76.96 (12.66) | 0.67 | 25.41 | 12.02–42.37 | 0.70 | 0.19–1.17 | 0.25 | 3.58 |
| Stroop Task | |||||||||
| Phase 2 | 100 | 99.16 (0.55) | 1.50 | 7.62 | 1.50–19.34 | 1.52 | 0.87–2.17 | 0.08 | 4.11 |
| Phase 3 | 100 | 98 (0.75) | 2.67 | 0.87 | 0.02–4.37 | 2.66 | 1.71–3.61 | 0.011 | 3.30 |
| OSARI | |||||||||
| Stop Trial | 77.08 | 69.23 (6.80) | 1.12 | 13.75 | 4.34–28.35 | 1.51 | 0.57–1.71 | 0.14 | 2.34 |
[i] Abbreviations. Bayes Factor (BF), Hayling Sentence Completion (HSCT), Open-Source Anticipated Response Inhibition Task (OSARI).
*Please note due to technical issues the Go/No-Go comparisons are between HSAM and 19 controls.
1Please note this value is not significant when accounting for multiple testing.
Table 2
Test of Deficit results and BF values for response times (RT) (HSAM vs. controls).
| TASK | HSAM | CONTROLS | T | ESTIMATED % OF CONTROL POPULATION BELOW DT’S SCORE | ESTIMATED EFFECT SIZE (ZCASE-CONTROLS) | p | BF | ||
|---|---|---|---|---|---|---|---|---|---|
| RT (S) | MEAN RT (S) (SD) | (%) | (95% CI) | POINT | (95% CI) | ||||
| Simon Task | |||||||||
| Compatible | 0.48 | 0.45 (0.66) | 0.04 | 51.75 | 34.64–68.57 | 0.05 | –0.40–0.48 | 0.52 | 3.46 |
| Incompatible | 0.54 | 0.49 (0.68) | 0.07 | 52.82 | 35.68–69.56 | 0.07 | –0.37–0.51 | 0.53 | 2.27 |
| Go/No-Go | |||||||||
| Overall | 0.35 | 0.34 (0.02) | 0 | 50.00 | 33.06–66.94 | 0 | –0.44–0.44 | 0.50 | 4.47 |
| HSCT | |||||||||
| Phase 1 | 1.02 | 1.48 (0.38) | –1.18 | 12.60 | 3.73–26.83 | –1.21 | –1.78––0.62 | 0.13 | 2.20 |
| Phase 2 | 3.70 | 2.88 (1.04) | 0.77 | 77.45 | 60.89–90.06 | 0.78 | 0.28–1.28 | 0.77 | 3.29 |
| Stroop Task | |||||||||
| Phase 1 | 23.70 | 17.12 (4.18) | 1.53 | 92.96 | 81.62–98.71 | 1.57 | 0.90–2.23 | 0.93 | 1.34 |
| Phase 2 | 19.01 | 17.23 (3.00) | 0.58 | 71.53 | 54.30–85.66 | 0.60 | 0.11–1.07 | 0.72 | 3.82 |
| Phase 3 | 25.38 | 25.00 (4.21) | 0.09 | 53.46 | 36.31–70.14 | 0.09 | –0.35 –0.53 | 0.53 | 4.56 |
| OSARI | |||||||||
| Go Trial | 0.84 | 0.80 (0.02) | 1.95 | 96.7 | 88.91–99.71 | 2.00 | 1.22–2.76 | 0.97 | 2.45 |
| Stop Trial | 0.76 | 0.78 (0.06) | 0.76 | 77.45 | 60.89–90.06 | 0.78 | 0.28–1.28 | 0.77 | 3.96 |
[i] Abbreviations. Bayes Factor (BF), Hayling Sentence Completion (HSCT), Open-Source Anticipated Response Inhibition Task (OSARI).
*Please note due to technical issues the Go/No-Go comparisons are between HSAM and 19 controls.
Figure 1
Overview of inhibition task results (accuracy and RT). DT’s performance relative to the control sample is depicted by red vertical lines. Stroop accuracy is not included as performance for all participants was at ceiling.